The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Glipizide and Metformin HCl
Glipizide and Metformin HCl · GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 · Tablet, Film Coated · Oral · Proficient Rx LP
NDC 71205-0270-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for glipizide and metformin hcl (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Proficient Rx LPUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA078728
- TE code
- AB
- Approval date
- Jun 23, 2010
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Glipizide and Metformin HCl (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Chartwell RX, LLC | GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Glipizide and Metformin HCl — NDC 71205-0270-30," retrieved September 3, 2026, https://drugdashboards.com/drug/71205027030.
Free to cite with attribution — see how the data is put together.